Scholarlink

Background <p>Head and neck cancers, including oral and oropharyngeal squamous cell carcinomas (SCC), impact significant global health challenges. This study aimed to evaluate plasma cytokine profiles in patients with oral and oropharyngeal SCC compared to healthy donors to explore potential diagnostic biomarkers.</p> Methods <p>Plasma samples from 18 healthy donors, 11 oral cancer patients, and 11 oropharyngeal cancer patients were analysed using LEGENDplex™ multiplex assays to quantify 49 cytokines and inflammatory proteins. Statistical analysis, including Mann-Whitney U test and ROC curve analysis, was performed to assess diagnostic utility.</p> Results <p>sFasL levels were significantly downregulated in cancer patients, whereas PECAM-1, FGF-basic, EPO, PDGF-AA, and PDGF-BB levels were upregulated. Combined analysis of PDGF-AA and PDGF-BB achieved a sensitivity of 98.38% and specificity of 73.87% for oral cancer diagnosis. PECAM-1 demonstrated 100% sensitivity for detecting oropharyngeal cancer. </p> Conclusion <p>These preliminary findings suggest that alterations in plasma levels of sFasL, PECAM-1, FGF-basic, EPO, PDGF-AA, and PDGF-BB suggest their potential as early diagnostic markers for oral and oropharyngeal SCC. Larger cohort studies are warranted to validate these findings and to develop screening strategies for head and neck cancers.</p> Trial registration <p>The study protocol was approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University (IRB 810/62, Bangkok, Thailand) and adhered to the Declaration of Helsinki. Written informed consent was obtained from all participants.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Plasma cytokine profiles in oral and oropharyngeal squamous cell carcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月3日

查看全文
  • Patnarin Mahattanasakul,
  • Komkrit Ruangritchankul,
  • Areeya Diloktaweewattana,
  • Supranee Buranapraditkun,
  • Nakarin Kitkumthorn

摘要

Background

Head and neck cancers, including oral and oropharyngeal squamous cell carcinomas (SCC), impact significant global health challenges. This study aimed to evaluate plasma cytokine profiles in patients with oral and oropharyngeal SCC compared to healthy donors to explore potential diagnostic biomarkers.

Methods

Plasma samples from 18 healthy donors, 11 oral cancer patients, and 11 oropharyngeal cancer patients were analysed using LEGENDplex™ multiplex assays to quantify 49 cytokines and inflammatory proteins. Statistical analysis, including Mann-Whitney U test and ROC curve analysis, was performed to assess diagnostic utility.

Results

sFasL levels were significantly downregulated in cancer patients, whereas PECAM-1, FGF-basic, EPO, PDGF-AA, and PDGF-BB levels were upregulated. Combined analysis of PDGF-AA and PDGF-BB achieved a sensitivity of 98.38% and specificity of 73.87% for oral cancer diagnosis. PECAM-1 demonstrated 100% sensitivity for detecting oropharyngeal cancer.

Conclusion

These preliminary findings suggest that alterations in plasma levels of sFasL, PECAM-1, FGF-basic, EPO, PDGF-AA, and PDGF-BB suggest their potential as early diagnostic markers for oral and oropharyngeal SCC. Larger cohort studies are warranted to validate these findings and to develop screening strategies for head and neck cancers.

Trial registration

The study protocol was approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University (IRB 810/62, Bangkok, Thailand) and adhered to the Declaration of Helsinki. Written informed consent was obtained from all participants.